Tiger Brokers

热门话题-Avalo股价大涨，因皮肤病药物在中期试验中显示出潜在疗效

路透中文
May 06
热门话题-Avalo股价大涨，因皮肤病药物在中期试验中显示出潜在疗效

5月6日 - ** Avalo Therapeutics AVTX.O 股价盘前大涨43%，至23.26美元

** 该公司周二晚间表示，其用于治疗一种疼痛性慢性皮肤病的实验性药物达到了中期试验的主要目标

** 阿瓦洛正在研发名为abdakibart的药物，用于治疗化脓性汗腺炎患者。该病症会导致皮肤下反复出现发炎的肿块和脓肿，主要发生在腋下和腹股沟区域

** 该药物帮助约42%的患者在16周时实现了显著的皮肤症状缓解，而接受安慰剂的患者中这一比例为25.6%

** “我们对这一疗效的显著性印象深刻，”Wedbush分析师德里斯科尔（Robert Driscoll）表示

** Avalo计划推进abdakibart进入更大规模的后期临床试验

** 此外，Avalo还宣布将进行公开股票发行，预计筹集约3.75亿美元，用于资助abdakibart的研发

** 截至上一交易日收盘，该公司股价年内累计下跌10.5%

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10